Pfizer plans to seek COVID-19 vaccine authorization 'within days'
Pfizer's COVID-19 vaccine candidate has been found to be 95 percent effective in a final analysis, and the company plans to seek emergency use authorization in just a matter of days.
Pfizer and BioNTech on Wednesday announced that a final analysis of its coronavirus vaccine's phase three trial showed it was 95 percent effective against COVID-19, as of the 170 coronavirus cases reported in the trial, only eight were among those who received the vaccine, CNN reports.
Pfizer and BioNTech are planning to apply for emergency use authorization from the Food and Drug Administration for the vaccine "within days," ABC News reports. The FDA had required two months of safety data in order to seek emergency use authorization, a milestone Pfizer has achieved.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The companies also said Wednesday that "efficacy was consistent across age, race and ethnicity demographics," and the "observed efficacy in adults over 65 years of age was over 94 percent," per CNN. There have not been "any serious safety concerns related to the vaccine" reported, they said. Pfizer previously announced that an interim analysis suggested the vaccine candidate was more than 90 percent effective.
Moderna earlier this week also announced that its own coronavirus vaccine candidate appears to be nearly 95 percent effective. Both of these efficacy rates were far better than experts had been anticipating from a coronavirus vaccine. Once a vaccine against COVID-19 is approved, high-risk groups like health-care workers are expected to receive it first, and Pfizer and BioNTech say they can produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Why is a government shutdown possible before the election?
Today's Big Question A fight over immigration, spending and the future of House Speaker Mike Johnson
By Joel Mathis, The Week US Published
-
DOJ charges 2 in white nationalist 'Terrorgram' plot
Feds say Dallas Humber and Matthew Allison were plotting assassinations through a terrorist network on Telegram
By Peter Weber, The Week US Published
-
Dozens dead in Vietnam after 'worst typhoon' in 30 years
At least 58 people are dead and hundreds are missing after Typhoon Yagi made landfall
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published